Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss July 15, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Texas governor demands action from CenterPoint over power failures Back: All Posts Next:AEWIN Performant Storage Server, BIS-5121A/5222A Series, has been Applied to Reliable Backup and Recovery Solutions